Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Change in Receivables (2019 - 2026)

Biodesix filings provide 8 years of Change in Receivables readings, the most recent being $488000.0 for Q1 2026.

  • On a quarterly basis, Change in Receivables rose 153.98% to $488000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $1.9 million, a 233.82% increase, with the full-year FY2025 number at $531000.0, down 70.68% from a year prior.
  • Change in Receivables hit $488000.0 in Q1 2026 for Biodesix, up from -$3.6 million in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $5.2 million in Q3 2025 to a low of -$3.6 million in Q4 2025.
  • Median Change in Receivables over the past 5 years was $325000.0 (2024), compared with a mean of $532294.1.
  • Biggest five-year swings in Change in Receivables: surged 7003.03% in 2024 and later tumbled 460.44% in 2025.
  • Biodesix's Change in Receivables stood at $736000.0 in 2022, then soared by 380.98% to $3.5 million in 2023, then tumbled by 71.72% to $1.0 million in 2024, then tumbled by 460.44% to -$3.6 million in 2025, then skyrocketed by 113.53% to $488000.0 in 2026.
  • The last three reported values for Change in Receivables were $488000.0 (Q1 2026), -$3.6 million (Q4 2025), and $5.2 million (Q3 2025) per Business Quant data.